Dalton Investments’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,384
Closed -$113K 27
2022
Q3
$113K Hold
16,384
0.09% 27
2022
Q2
$137K Hold
16,384
0.12% 27
2022
Q1
$374K Hold
16,384
0.26% 18
2021
Q4
$452K Hold
16,384
0.3% 18
2021
Q3
$456K Hold
16,384
0.33% 18
2021
Q2
$480K Sell
16,384
-31,382
-66% -$951K 0.26% 24
2021
Q1
$1.52M Hold
47,766
0.83% 20
2020
Q4
$994K Sell
47,766
-10,191
-18% -$190K 0.49% 29
2020
Q3
$901K Hold
57,957
0.59% 30
2020
Q2
$1.06M Hold
57,957
0.77% 28
2020
Q1
$898K Buy
+57,957
New +$1.4M 0.7% 30

Other funds holding BHC

Dalton Investments's BHC Position: Q4 2022 in Review

Dalton Investments sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 16,384 shares — an estimated $113K sold.

Dalton Investments first reported a position in BHC in Q1 2020 and held it in 11 quarters. The position peaked at $1.52M in Q1 2021. 260 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

  • Dalton Investments reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
  • Dalton Investments sold 16,384 Bausch Health shares in Q4 2022, an estimated $113K.
  • Dalton Investments first reported a position in Bausch Health in Q1 2020 and held it in 11 quarters.
  • Dalton Investments's Bausch Health position peaked at $1.52M in Q1 2021.
  • 260 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Dalton Investments's 13F filing for Q4 2022, filed 14 Feb 2023.